Furthermore, elevated expression of Crk or CrkL correlated with the poor prognosis in GBM (9), lung cancer (16, 43), gastric cancer (19), ovarian cancer (44), oral squamous cell carcinoma (25), pancreatic cancer (29), and colorectal cancer (30). This evidence concerns the gene CRKL and glioblastoma.